Hyperfine initiated with a Buy at Lake Street

Lake Street analyst Frank Takkinen initiated coverage of Hyperfine (HYPR) with a Buy rating and $1.50 price target Hyperfine’s ultra-low field MR imaging system, Swoop, provides diagnostic quality brain imaging at the bedside and the company is also collecting clinical data to support use in new indications and settings of care to expand the total addressable market, the analyst tells investors. The firm believes “a robust foundation has been built,” with new indications expected to drive growth and margin expansion, the analyst added.